drugset

drugset / Trial / NCT00223561

Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder

NCT00223561 ↗

Phase 4 Completed 18 enrolled Utrecht Institute for Pharmaceutical Sciences

RandomizedCrossoverDouble-blindPrevention

Summary

The primary purpose of this study is to determine the effects of methylphenidate versus placebo on driving ability of adult ADHD patients.

Timeline

Start: 2003-02
Primary completion: —
Completion: 2006-02

Publications

Verster JC, Bekker EM, Kooij JJ, Buitelaar JK, Verbaten MN, Volkerts ER, Olivier B. Methylphenidate significantly improves declarative memory functioning of adults with ADHD. Psychopharmacology (Berl). 2010 Oct;212(2):277-81. doi: 10.1007/s00213-010-1952-2. Epub 2010 Jul 20.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Methylphenidate	Small molecule	14.7 mg	—

Indications